The association of brain natriuretic peptide and insulin resistance in obesity-related hypertension

Journal of Human Hypertension

Volumn 21, Issue 7, 2007, Pages 546-550

  Tekes, S ^a   Cikim, A S ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GLUCOSE; INSULIN;

ADULT; ANTHROPOMETRY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; OBESITY; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; NATRIURETIC PEPTIDE, BRAIN; OBESITY;

EID: 34347383340     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002194     Document Type: Article

References (21)

1. Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: Results from the Dallas Heart Study. Circulation 2005; 112: 2163-2168.
2. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients. Am Heart J 1998; 135: 825-832.
3. Hammerer-Lercher A, Neubauer E, Muller S, Pachineger O, Puschhendorf B, Mair J. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 2001; 310: 193-197.
4. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109: 594-600.
5. Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris BC et al. Obesity and supresssed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004; 43: 1590-1595.
6. McCord J, Mundy BJ, Hudson MP. Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med 2004; 164: 2247-2252.
7. Dessi-Fulgheri P, Paci MV, Tamburrini P, Moraca A, Espinosa E, Cola G et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens 1997; 15: 1695-1699.
8. Buckley MG, Markandu ND, Miller MA, Sagnella GA, MacGregor GA. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens 1993; 7: 245-250.
9. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374-381.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 Report. JAMA 2003; 289: 2560-2572.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetes 1985; 28: 412-419.
12. Katz A, Nambii SS, Mather K, Baron AD, Follmann DA, Sullivan G et al. Quantative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410.
13. World Health Report. Reducing Risks, Promoting Healthy Life. World Health Orgaization: Geneva, Switzerland, 2002.
14. Schillaci G, Pasqualini L, Vaudo G, Lupattelli G, Pirro M, Gemelli F et al. Effect of body weight changes on 24-h blood pressure and left ventricular mass in hypertension: A 4-year follow-up. Am J Hypertens 2003; 16: 634-639.
15. Sarzani R, Dessi-Fulgheri P, Salvi F, Serenelli M, Spagnolo D, Cola G et al. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypertens 1999; 17: 1301-1305.
16. Ohno Y, Suzuki H, Yamakawa H, Nakamura M, Kato Y, Saruta T. Correlation of sodium-related factors with insulin sensitivity in young, lean, male offspring of hypertensive and normotensive subjects. J Hum Hypertens 2001; 15: 393-399.
17. Tanabe A, Naruse M, Wasada T, Naruse K, Yoshimoto T, Omori Y et al. Effects of acute hyperinsulinemia on plasma atrial and brain natriuretic peptide concentrations. Eur J Endocrinol 1995; 132 693-698.
18. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28: 22-30.
19. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992; 92: 29-34.
20. Conen D, Pfisterer M, Martina B. Substantial intraindividual variability of BNP concentrations in patients with hypertension. J Hum Hypertens 2006; 20: 387-391.
21. Bruins SM, Fokkema R, Römer JWP, DeJongste MJL, van der Dijs FPL, van den Ouweland JMW et al. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 2004; 50: 2052-2058.